Lloyd’s of London as an overseas expansion platform for Asian insurers: Lloyd’s offers Asian insurers global specialty access, but capital discipline—not expansion alone—determines value creation

Overview

This first report in JPMorgan’s “Going West” series examines Lloyd’s of London as an overseas-expansion platform for Asian insurers. It concludes that Lloyd’s offers valuable global access and specialty diversification, but reported margins must be judged against long-tail reserve risk, capital requirements, cycle volatility and the need to preserve shareholder returns.

Core views

JPMorgan argues that Lloyd’s remains one of the most compelling routes for Asian insurers seeking overseas diversification. A Lloyd’s platform provides rights to write insurance and reinsurance in more than 200 countries and markets through one marketplace, avoiding the slower, more capital-intensive process of building licences, branches, regulatory relationships and local operations country by country. This is particularly advantageous relative to the United States, where separate authorisation is required across 50 states. For insurers concentrated in mature domestic personal lines such as motor, fire and short-term health, Lloyd’s also opens access to broker-originated global specialty risks including cyber, terrorism, energy, marine, aviation and political risk. The strategic attraction does not, however, make Lloyd’s a straightforward higher-ROE proposition. Specialty lines can have stronger pricing power and lower reported combined ratios than Asian domestic non-life books, where combined ratios are typically around 95% versus sub-90% at some Lloyd’s agents. But these businesses are complex, less standardised and often long-tail. Claims may emerge over years or decades, while legal, economic and social inflation can make ultimate losses and reserve adequacy more important to long-run profitability than the initial combined ratio. JPMorgan notes signs that specialty-market pricing is worsening in 2026, reinforcing the market’s cyclicality and the wider range of potential earnings outcomes relative to personal-lines businesses. The report identifies reserve and premium risk as the central capital constraint. Under severe 1-in-200 or 1-in-250-year stress scenarios, aggregate specialty premium and reserve risk exceeds catastrophe risk. Lloyd’s FY25 SFCR reported GBP32.383B of non-life premium and reserve risk, compared with GBP9.910B of non-life catastrophe risk. Catastrophe exposures are substantial but more visible and actively managed through excess-of-loss reinsurance, probable maximum loss limits, aggregate controls and Lloyd’s Realistic Disaster Scenarios. In contrast, adverse development in long-duration specialty books can accumulate across several underwriting years, creating a persistent earnings and capital drain that is harder to cap or reinsure away. Historical experience illustrates this distinction. Asbestos, pollution and health-hazard liabilities written decades earlier generated about GBP16B of market losses between 1988 and 1992 and led to Equitas being created in 1996 to ring-fence pre-1993 liabilities. The 1989-92 London Market Excess of Loss spiral produced about GBP4.6B of losses as reinsurance repeatedly recycled the same underlying exposures. Later, soft pricing and US social inflation drove multiyear reserve deterioration in casualty and specialty lines during 2015-19, contributing to Lloyd’s 2018 Decile 10 review. The report nevertheless considers the market more resilient today: franchise guidelines and performance management introduced from 2003 strengthened business-plan monitoring and capital requirements, while the 2017 combined ratio of 114% was below the 120-150% levels seen in late soft markets of the 1980s and 1990s. S&P upgraded Lloyd’s to AA- in December 2023, citing tighter syndicate controls and improved performance. Capital intensity limits how much attractive underwriting conditions can translate into equity returns. Lloyd’s managing agents commonly keep underwriting premium relative to allocated capital below 1x in order to protect solvency, ratings and franchise value. Lloyd’s uses an ultimate reserving approach that is more conservative than Solvency II’s 12-month perspective, which supports resilience but underscores the capital burden of long-tail risks. The report also notes that Tier 2 capital, including letters of credit, can make group-level ROEs appear stronger than the capital deployed within the Lloyd’s platform would suggest. The relevant test for an Asian acquirer is therefore whether returns exceed the cost of equity after reserve risk, tail volatility, capital needs and integration risk—not whether headline underwriting margins look higher. JPMorgan uses Tokio Marine as the key valuation case study. Its overseas pretax profit rose from 21% of group adjusted profit in FY3/08 to 39% in FY3/26 after major acquisitions, while its adjusted P/B re-rated from 0.84x in FY3/18 to 1.94x FY3/27E based on the 11 September 2026 share price. Its share price rose 399% since 2017, versus 165% for TOPIX. Yet the report argues that overseas acquisitions beginning in 2008 were not initially a valuation catalyst. The re-rating became more convincing only after Tokyo Marine made stronger shareholder-return commitments from 2017, including sizeable buybacks and a higher TSR policy, alongside domestic cost reductions, productivity gains and North American growth. JPMorgan’s lesson is that overseas growth plus capital discipline, rather than overseas growth alone, drove the improved equity narrative. This conclusion is especially relevant for Samsung F&M’s potential expansion into a Lloyd’s agent through Canopius. Higher risk-free rates raise the cost of equity and therefore the required return on overseas M&A; Japan’s and Korea’s 10-year government bond yields were 2.98% and 4.54%, respectively, on 11 September 2026. JPMorgan argues that capital deployed to a Lloyd’s acquisition must not undermine dividends or buybacks. For Asian insurers, Lloyd’s is a strategic option for business-mix improvement and global specialty access, but it is not a substitute for disciplined capital management. The report prefers QBE and DB Insurance among Asian non-life insurers, T&D Holdings among Japanese insurers, and Meiji Yasuda Life in fixed income.

Analysis framework

JPMorgan assesses Lloyd’s through its licensing reach, specialty-business economics, capital and solvency disclosures, historical loss episodes, underwriting leverage and transaction comparisons. It then tests the strategic case against historical Asian insurer M&A outcomes and Tokio Marine’s valuation re-rating to distinguish the benefits of overseas growth from the effects of shareholder-return policy and capital discipline.

Methodology notes

• Industry AnalysisSupply-demand framework

  Specialty insurance pricing and underwriting-cycle analysis

  The report compares specialty pricing and margins with domestic personal lines, while noting worsening Lloyd’s pricing in 2026 and the effect of capacity and underwriting discipline on returns.

• Financial-sector metricsSolvency analysis

  Solvency capital requirement and reserve-risk analysis

  The report uses Lloyd’s SFCR risk components to show that premium and reserve risk, rather than catastrophe risk alone, is the dominant capital burden for specialty insurance.

• Valuation methodsPB valuation

  Adjusted price-to-book valuation comparison

  Tokio Marine’s adjusted P/B re-rating is used to assess what investors rewarded and to argue that capital returns were critical alongside overseas growth.

• Corporate Fundamentals and FinanceROIC–WACC spread

  Return relative to cost of equity

  JPMorgan frames the investment test as whether post-risk, post-capital returns from Lloyd’s expansion can exceed the cost of equity in a higher-rate environment.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

• QBE Insurance Group (QBE.AX)

  JPMorgan identifies QBE as a preferred Asian non-life insurance name.

  Strengths

  Preferred exposure within the report’s Asian non-life selection.

  Comparison

  Preferred alongside DB Insurance.

  Risks

  Specialty-insurance cycle, underwriting and capital-return risks discussed for the sector.

• DB Insurance Co Ltd (005830.KS)

  JPMorgan identifies DB Insurance as a preferred Asian non-life insurance name.

  Strengths

  Preferred exposure within the report’s Asian non-life selection.

  Comparison

  Preferred alongside QBE.

  Risks

  Capital deployment and shareholder-return execution remain relevant sector considerations.

• T&D Holdings (8795.T)

  JPMorgan prefers T&D Holdings among Japanese insurers.

  Strengths

  Preferred because JPMorgan sees limited additional upside from Japanese non-life insurers’ FY28E TSR yield at the 6-7% level.

  Comparison

  Preferred over Japanese non-life insurers in the report’s regional selection.

• Meiji Yasuda Life Insurance

  JPMorgan’s fixed-income top pick.

  Strengths

  Robust capital position, strong solvency ratio and remaining Tier 2 issuance capacity support resilience amid overseas M&A.

  Comparison

  Economic solvency ratio of 208% versus 197% for Sumitomo Life and 195% for Nippon Life.

  Risks

  Overseas M&A could pressure solvency, although the report views its capital position as providing comfort.

Key data

• Lloyd’s market accessMore than 200 marketsA single Lloyd’s platform provides global insurance and reinsurance access.
• Lloyd’s FY25 premium and reserve riskGBP32.383BNon-life premium and reserve risk under the SFCR capital framework.
• Lloyd’s FY25 catastrophe riskGBP9.910BBelow non-life premium and reserve risk, despite catastrophe losses being a visible source of claims.
• Typical Asian non-life combined ratioAround 95%Compared with sub-90% combined ratios at some Lloyd’s agents.
• Tokio Marine adjusted P/B0.84x FY3/18 to 1.94x FY3/27EFY3/27E multiple based on the 11 September 2026 share price.
• Tokio Marine share-price performance since 2017399%Compared with TOPIX performance of 165%.
• Japan and Korea 10-year government bond yields2.98% and 4.54%As of 11 September 2026; cited as evidence of a higher return hurdle for overseas M&A.
• Meiji Yasuda Life economic solvency ratio208%As of end-March, versus 197% for Sumitomo Life and 195% for Nippon Life.

Impact & implications

The report says Lloyd’s can improve Asian insurers’ business mix, diversification and specialty capability, but valuation support depends on proving risk-adjusted returns above the cost of equity while maintaining dividends, buybacks and solvency. For Samsung F&M in particular, a Lloyd’s transaction should be evaluated against the capital opportunity cost and the effect on shareholder returns.

Risks

• Long-tail specialty claims can produce reserve deterioration over multiple underwriting years and impose a persistent capital and earnings burden.
• Cyber, terrorism, energy, marine and aviation risks have complex and volatile claims patterns that require disciplined underwriting and deep data.
• Lloyd’s pricing shows signs of weakening in 2026, and specialty underwriting remains cyclical.
• Overseas acquisitions face execution, integration, goodwill and impairment risk.
• Capital allocated to overseas M&A could reduce dividends or buybacks and weaken the shareholder-return case.

What to watch

• Whether a prospective Samsung F&M Lloyd’s expansion preserves dividends, buybacks and disciplined capital management.
• Lloyd’s specialty-market pricing and underwriting conditions during 2026.
• Reserve development and the relative burden of premium and reserve risk in Lloyd’s solvency disclosures.
• Underwriting leverage, capital buffers and use of Tier 2 capital at Lloyd’s managing agents.
• Evidence that overseas returns exceed the higher cost of equity implied by elevated risk-free rates.